表紙
市場調查報告書

腎病症候群:全球臨床實驗趨勢

Nephrotic Syndrome Global Clinical Trials Review, H1, 2018

出版商 GlobalData 商品編碼 639219
出版日期 內容資訊 英文 147 Pages
訂單完成後即時交付
價格
腎病症候群:全球臨床實驗趨勢 Nephrotic Syndrome Global Clinical Trials Review, H1, 2018
出版日期: 2018年03月31日內容資訊: 英文 147 Pages
簡介

本報告提供腎病症候群治療藥臨床實驗相關的基本數據及資料,彙整實驗數量及受驗者的募集情況,各階段趨勢,實施臨床實驗的主要製藥企業及研究機關的簡介等資料。

本報告概要

調查範圍

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:泌尿生殖系統系及性荷爾蒙治療藥臨床實驗上腎病症候群的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:泌尿生殖系統系及性荷爾蒙治療藥臨床實驗上腎病症候群的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

腎病症候群治療藥臨床實驗參與的主要企業

有潛力的藥劑

臨床實驗簡介概要

附錄

目錄
Product Code: GDHC4859CTIDB

GlobalData's clinical trial report, "Nephrotic Syndrome Global Clinical Trials Review, H1, 2018" provides an overview of Nephrotic Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Nephrotic Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • GlobalData Clinical Trials Report Coverage 6
  • Clinical Trials by Region 7
  • Clinical Trials and Average Enrollment by Country 8
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 13
  • Top Countries Contributing to Clinical Trials in Central and South America 14
  • Clinical Trials by G7 Countries: Proportion of Nephrotic Syndrome to Genito Urinary System And Sex Hormones Clinical Trials 15
  • Clinical Trials by Phase in G7 Countries 16
  • Clinical Trials in G7 Countries by Trial Status 17
  • Clinical Trials by E7 Countries: Proportion of Nephrotic Syndrome to Genito Urinary System And Sex Hormones Clinical Trials 18
  • Clinical Trials by Phase in E7 Countries 19
  • Clinical Trials in E7 Countries by Trial Status 20
  • Clinical Trials by Phase 21
  • In Progress Trials by Phase 22
  • Clinical Trials by Trial Status 23
  • Clinical Trials by End Point Status 24
  • Subjects Recruited Over a Period of Time 25
  • Clinical Trials by Sponsor Type 26
  • Prominent Sponsors 27
  • Top Companies Participating in Nephrotic Syndrome Therapeutics Clinical Trials 28
  • Prominent Drugs 29
  • Clinical Trial Profile Snapshots 30

Appendix 145

  • Abbreviations 145
  • Definitions 145
  • Research Methodology 146
  • Secondary Research 146
  • About GlobalData 147
  • Contact Us 147
  • Source 147

List of Tables

  • Nephrotic Syndrome Therapeutics, Global, Clinical Trials by Region, 2018* 7
  • Nephrotic Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
  • Nephrotic Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9
  • Nephrotic Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 10
  • Nephrotic Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 11
  • Nephrotic Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2018* 12
  • Nephrotic Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 13
  • Nephrotic Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 14
  • Proportion of Nephrotic Syndrome to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2018* 15
  • Nephrotic Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16
  • Nephrotic Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17
  • Proportion of Nephrotic Syndrome to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2018* 18
  • Nephrotic Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19
  • Nephrotic Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 20
  • Nephrotic Syndrome Therapeutics, Global, Clinical Trials by Phase, 2018* 21
  • Nephrotic Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 22
  • Nephrotic Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23
  • Nephrotic Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2018* 24
  • Nephrotic Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 25
  • Nephrotic Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 26
  • Nephrotic Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 27
  • Nephrotic Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 28
  • Nephrotic Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 29

List of Figures

  • Nephrotic Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
  • Nephrotic Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
  • Nephrotic Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9
  • Nephrotic Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 10
  • Nephrotic Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 11
  • Nephrotic Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 12
  • Nephrotic Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 13
  • Nephrotic Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2018* 14
  • Proportion of Nephrotic Syndrome to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2018* 15
  • Nephrotic Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16
  • Nephrotic Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17
  • Proportion of Nephrotic Syndrome to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2018* 18
  • Nephrotic Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19
  • Nephrotic Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 20
  • Nephrotic Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2018* 21
  • Nephrotic Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 22
  • Nephrotic Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23
  • Nephrotic Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2018* 24
  • Nephrotic Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 25
  • Nephrotic Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 26
  • Nephrotic Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 27
  • Nephrotic Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 28
  • Nephrotic Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 29
  • GlobalData Methodology 146